Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry

• Understanding uncertainty in the COVID-19 pandemic is a priority for the industry. • Policy and population behavioral affect risk management in the short/mid-term. • Information around natural history unknowns will guide long-term risk management. • Our framework allows risk management and risk-sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Coudeville, L., Gomez, G.B., Jollivet, O., Harris, R.C., Thommes, E., Druelles, S., Chit, A., Chaves, S.S., Mahé, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552977/
https://www.ncbi.nlm.nih.gov/pubmed/33097312
http://dx.doi.org/10.1016/j.vaccine.2020.10.034
_version_ 1783593512865890304
author Coudeville, L.
Gomez, G.B.
Jollivet, O.
Harris, R.C.
Thommes, E.
Druelles, S.
Chit, A.
Chaves, S.S.
Mahé, C.
author_facet Coudeville, L.
Gomez, G.B.
Jollivet, O.
Harris, R.C.
Thommes, E.
Druelles, S.
Chit, A.
Chaves, S.S.
Mahé, C.
author_sort Coudeville, L.
collection PubMed
description • Understanding uncertainty in the COVID-19 pandemic is a priority for the industry. • Policy and population behavioral affect risk management in the short/mid-term. • Information around natural history unknowns will guide long-term risk management. • Our framework allows risk management and risk-sharing strategies discussions.
format Online
Article
Text
id pubmed-7552977
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75529772020-10-13 Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry Coudeville, L. Gomez, G.B. Jollivet, O. Harris, R.C. Thommes, E. Druelles, S. Chit, A. Chaves, S.S. Mahé, C. Vaccine Article • Understanding uncertainty in the COVID-19 pandemic is a priority for the industry. • Policy and population behavioral affect risk management in the short/mid-term. • Information around natural history unknowns will guide long-term risk management. • Our framework allows risk management and risk-sharing strategies discussions. The Author(s). Published by Elsevier Ltd. 2020-11-10 2020-10-13 /pmc/articles/PMC7552977/ /pubmed/33097312 http://dx.doi.org/10.1016/j.vaccine.2020.10.034 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Coudeville, L.
Gomez, G.B.
Jollivet, O.
Harris, R.C.
Thommes, E.
Druelles, S.
Chit, A.
Chaves, S.S.
Mahé, C.
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
title Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
title_full Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
title_fullStr Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
title_full_unstemmed Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
title_short Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
title_sort exploring uncertainty and risk in the accelerated response to a covid-19 vaccine: perspective from the pharmaceutical industry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552977/
https://www.ncbi.nlm.nih.gov/pubmed/33097312
http://dx.doi.org/10.1016/j.vaccine.2020.10.034
work_keys_str_mv AT coudevillel exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT gomezgb exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT jolliveto exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT harrisrc exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT thommese exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT druelless exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT chita exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT chavesss exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry
AT mahec exploringuncertaintyandriskintheacceleratedresponsetoacovid19vaccineperspectivefromthepharmaceuticalindustry

Ejemplares similares